
Carolyn Rafieymehr / Wikimedia Commons / Public domain
Clinical Trials/July 1, 2026/3 min read
Recruiting Type 1 diabetes trials watch: what changed in the current registry feed
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
clinical trialsClinicalTrials.govT1Dtrial matching
What this is and is not
This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.
A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?
Recruiting records to inspect
- Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis — RECRUITING, NA. Interventions: UBLoop System. Locations: Bern, Canton of Bern, Switzerland. The study is investigating the early feasibility of a novel algorithm for a hybrid closed-loop (HCL) insulin delivery system in...Source
- Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D) — RECRUITING, PHASE4. Interventions: Insulin, DEXCOM Continuous Glucose Monitor. Locations: Columbus, Ohio, United States. PRISM-TID is a single center non-inferiority randomized controlled trial of permissive intrapartum...Source
- Intensive Dietary and Activity Counselling (IDAC) — RECRUITING, NA. Interventions: IDAC+. Locations: Malmö, Sweden. The aim of this intervention study is to investigate if a intensive dietary and physical activity counselling during the first two years of life in childre...Source
- Establishment of Screening Pathway for High-Risk Population of Type 1 Diabetes — RECRUITING. Interventions: Gene polymorphic detection. Locations: Beijing, Beijing Municipality, China. This study aims to establish a system for identifying and screening high-risk individuals for type 1 diabetes (T1D)...Source
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus — RECRUITING, PHASE1, PHASE2. Interventions: OPF-310. Locations: Chicago, Illinois, United States. This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of...Source
- Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) — RECRUITING, NA. Interventions: Investigational Procedure. Locations: Jeddah, Mecca Region, Saudi Arabia | Abu Dhabi, United Arab Emirates. The aim of this research is to identify pre-symptomatic Type 1 Diabetes (T1D) in...Source
- Cardiovascular Risk in Children With Chronic Conditions Study — RECRUITING. Locations: Budapest, Hungary | Budapest, Hungary | Budapest, Hungary. Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to...Source
- A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes — RECRUITING, PHASE3. Interventions: Intervention Period 1: Semaglutide + Empagliflozin, Intervention Period 2: Semaglutide + Empagliflozin Placebo, Intervention Period 3: Semaglutide Placebo + Empagliflozin. Locations: M...Source
Questions before contacting a study
- Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
- What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
- Can the family discuss the official record with their endocrinology team before sharing additional personal health details?
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.